US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy
Krishnan S, Chaisson RE
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024-03
Abstract
The provision of tuberculosis-preventive therapy (TPT) to vulnerable populations is critical for global control. Shorter-course TPT regimens are highly effective and improve completion rates. Despite incorporation of 1 month of rifapentine and isoniazid into global guidelines, current US TPT guidelines do not include this as a recommended regimen, but should.
MeSH terms
- Humans
- Tuberculosis
- Isoniazid
- Antitubercular Agents
- Antibiotic Prophylaxis
- Drug Therapy, Combination
- Latent Tuberculosis